We are live on ! Find out more
PAMU

Pictet Asset Management (UK) Portfolio holdings

AUM $91.8B
1-Year Est. Return 47.77%
This Fund
S&P 500
This Quarter Est. Return
+6.27%
1 Year Est. Return
+47.77%
3 Year Est. Return
+102.96%
5 Year Est. Return
+189.45%
10 Year Est. Return
AUM
$22.3B
AUM Growth
+$1.56B
Cap. Flow
+$509M
Cap. Flow %
2.28%
Top 10 Hldgs %
13.76%
Holding
912
New
47
Increased
563
Reduced
217
Closed
37

Top Buys

Rank Stock Value
1
SRE icon
Sempra
SRE
+$42M
2
PII icon
Polaris
PII
+$34.8M
3
K
Kellanova
K
+$31.8M
4
CNP icon
CenterPoint Energy
CNP
+$30.6M
5
D icon
Dominion Energy
D
+$30.3M

Top Sells

Rank Stock Value
1
VZ icon
Verizon
VZ
+$124M
2
KMI icon
Kinder Morgan
KMI
+$102M
3
PAGP icon
Plains GP Holdings
PAGP
+$76M
4
OKE icon
Oneok
OKE
+$57.8M
5
NKE icon
Nike
NKE
+$53.4M

Sector Composition

Rank Sector Weight
1 Utilities 16.63%
2 Healthcare 12.32%
3 Industrials 11.87%
4 Technology 11.17%
5 Consumer Discretionary 10.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IFEU
826
DELISTED
iShares Europe Developed Real Estate ETF
IFEU
$354K ﹤0.01%
9,700
VALE.P
827
DELISTED
Vale S A
VALE.P
$307K ﹤0.01%
42,234
-2,091
-5% -$16.9K
WPX
828
DELISTED
WPX Energy, Inc.
WPX
$263K ﹤0.01%
22,590
+22,580
+225,800% +$360K
RYAAY icon
829
Ryanair
RYAAY
$30.9B
$250K ﹤0.01%
8,543
-3,864
-31% -$96.6K
TD icon
830
Toronto Dominion Bank
TD
$200B
$222K ﹤0.01%
4,636
XLB icon
831
State Street Materials Select Sector SPDR ETF
XLB
$8.71B
$222K ﹤0.01%
9,140
-5,600
-38% -$135K
AMPH icon
832
Amphastar Pharmaceuticals
AMPH
$896M
$207K ﹤0.01%
17,800
MFC icon
833
Manulife Financial
MFC
$73.3B
$121K ﹤0.01%
6,352
VVUS
834
DELISTED
Vivus Inc
VVUS
$106K ﹤0.01%
3,690
CHT icon
835
Chunghwa Telecom
CHT
$32.8B
$103K ﹤0.01%
3,513
+156
+5% +$4.66K
HII icon
836
Huntington Ingalls Industries
HII
$13B
$99K ﹤0.01%
883
KEYS icon
837
Keysight
KEYS
$57.3B
$96K ﹤0.01%
+2,850
New +$93.1K
VALE icon
838
Vale
VALE
$63.4B
$77K ﹤0.01%
9,441
+419
+5% +$3.92K
AMCX icon
839
AMC Global Media
AMCX
$489M
$67K ﹤0.01%
1,050
XLS
840
DELISTED
EXELIS INC COM STK
XLS
$61K ﹤0.01%
3,500
MUSA icon
841
Murphy USA
MUSA
$10.2B
$57K ﹤0.01%
825
SAN icon
842
Banco Santander
SAN
$210B
$49K ﹤0.01%
6,275
-136
-2% -$1.09K
TIME
843
DELISTED
Time Inc.
TIME
$48K ﹤0.01%
1,937
AVNS
844
DELISTED
Avanos Medical
AVNS
$46K ﹤0.01%
+1,003
New +$39.4K
WPG
845
DELISTED
Washington Prime Group Inc.
WPG
$46K ﹤0.01%
297
BBVA icon
846
Banco Bilbao Vizcaya Argentaria
BBVA
$156B
$43K ﹤0.01%
4,793
+37
+0.8% +$377
PRA
847
DELISTED
ProAssurance
PRA
$41K ﹤0.01%
+900
New +$41.2K
SAIC icon
848
Saic
SAIC
$5.3B
$39K ﹤0.01%
785
OGS icon
849
ONE Gas
OGS
$4.96B
$37K ﹤0.01%
900
KN icon
850
Knowles
KN
$3.27B
$34K ﹤0.01%
1,450

Similar funds

Pictet Asset Management (UK)'s Q4 2014 Portfolio in Review

As of Q4 2014, Pictet Asset Management (UK) held 912 positions worth $22.3B, up 7.5% from $20.8B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Pictet Asset Management (UK)'s Q4 2014 filing shows 47 new, 563 increased, 217 reduced and 37 closed positions. Its largest new stake was Sunstone Hotel Investors: 1,623,727 shares worth $26.8M. The largest sale was Verizon, an estimated $124M.

By sector, the portfolio is most concentrated in Utilities at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Industrials.

  • Pictet Asset Management (UK)'s largest Q4 2014 buy was Sunstone Hotel Investors: 1,623,727 shares worth $26.8M.
  • Pictet Asset Management (UK) added most to Sempra in Q4 2014, an estimated $42M increase.
  • Pictet Asset Management (UK)'s biggest Q4 2014 reduction was Verizon, cutting an estimated $124M.
  • Pictet Asset Management (UK) fully exited Plains All American Pipeline in Q4 2014, selling an estimated $52.5M.
  • Pictet Asset Management (UK)'s ten largest holdings make up 14% of its $22.3B portfolio in Q4 2014.
  • Pictet Asset Management (UK) opened 47 new positions and closed 37 in Q4 2014.
  • Pictet Asset Management (UK)'s portfolio value rose 7.5% quarter-over-quarter to $22.3B.

Based on Pictet Asset Management (UK)'s 13F filing for Q4 2014, filed 12 Feb 2015.